Suppr超能文献

马拉维的儿科淋巴瘤患者在诊断时的健康相关生活质量较差,并且在整个治疗和随访过程中在所有儿科 PROMIS-25 领域均有所改善。

Pediatric lymphoma patients in Malawi present with poor health-related quality of life at diagnosis and improve throughout treatment and follow-up across all Pediatric PROMIS-25 domains.

机构信息

UNC Project-Malawi, Lilongwe, Malawi.

University of North Carolina, Chapel Hill, North Carolina, USA.

出版信息

Pediatr Blood Cancer. 2021 Oct;68(10):e29257. doi: 10.1002/pbc.29257. Epub 2021 Aug 2.

Abstract

BACKGROUND

Patient-reportedoutcomes (PROs) that assess health-related quality of life (HRQoL) are increasingly important components of cancer care and research that are infrequently used in sub-Saharan Africa (SSA).

METHODS

We administered the Chichewa Pediatric Patient-Reported Outcome Measurement Information System Pediatric (PROMIS)-25 at diagnosis, active treatment, and follow-up among pediatric lymphoma patients in Lilongwe, Malawi. Mean scores were calculated for the six PROMIS-25 HRQoL domains (Mobility, Anxiety, Depressive Symptoms, Fatigue, Peer Relationships, Pain Interference). Differences in HRQoL throughout treatment were compared using the minimally important difference (MID) and an ANOVA analysis. Kaplan-Meier survival estimates and Cox hazard ratios for mortality are reported.

RESULTS

Seventy-five children completed PROMIS-25 surveys at diagnosis, 35 (47%) during active treatment, and 24 (32%) at follow-up. The majority of patients died (n = 37, 49%) or were lost to follow-up (n = 6, 8%). Most (n = 51, 68%) were male, median age was 10 (interquartile range [IQR] 8-12), 48/73 (66%) presented with advanced stage III/IV, 61 (81%) were diagnosed with Burkitt lymphoma and 14 (19%) Hodgkin lymphoma. At diagnosis, HRQoL was poor across all domains, except for Peer Relationships. Improvements in HRQoL during active treatment and follow-up exceeded the MID. On exploratory analysis, fair-poor PROMIS Mobility <40 and severe Pain Intensity = 10 at diagnosis were associated with increased mortality risk and worse survival, but were not statistically significant.

CONCLUSIONS

Pediatric lymphoma patients in Malawi present with poor HRQoL that improves throughout treatment and survivorship. Baseline PROMIS scores may provide important prognostic information. PROs offer an opportunity to include patient voices and prioritize holistic patient-centered care in low-resource settings.

摘要

背景

患者报告的结局(PROs)评估健康相关生活质量(HRQoL),在癌症治疗和研究中日益重要,但在撒哈拉以南非洲(SSA)却很少使用。

方法

我们在马拉维利隆圭的儿科淋巴瘤患者中,在诊断、积极治疗和随访时,使用切奇瓦语儿科患者报告结局测量信息系统儿科(PROMIS)-25 进行评估。计算了六个 PROMIS-25 HRQoL 领域(移动性、焦虑、抑郁症状、疲劳、同伴关系、疼痛干扰)的平均得分。使用最小重要差异(MID)和方差分析比较整个治疗过程中的 HRQoL 差异。报告了死亡率的 Kaplan-Meier 生存估计和 Cox 风险比。

结果

75 名儿童在诊断时完成了 PROMIS-25 调查,35 名(47%)在积极治疗时,24 名(32%)在随访时。大多数患者死亡(n=37,49%)或失访(n=6,8%)。大多数(n=51,68%)为男性,中位年龄为 10 岁(四分位间距 [IQR] 8-12),48/73(66%)表现为晚期 III/IV 期,61 名(81%)被诊断为伯基特淋巴瘤,14 名(19%)为霍奇金淋巴瘤。在诊断时,除同伴关系外,所有领域的 HRQoL 都很差。在积极治疗和随访期间,HRQoL 得到改善,超过了 MID。探索性分析显示,诊断时的 PROMIS 移动性<40 和严重疼痛强度=10 的一般较差评分与死亡率增加和生存状况恶化相关,但无统计学意义。

结论

马拉维的儿科淋巴瘤患者在治疗和生存期间表现出较差的 HRQoL,且随着治疗和生存的改善而改善。基线 PROMIS 评分可能提供重要的预后信息。PROs 提供了一个机会,可以在资源匮乏的环境中纳入患者的意见,并优先考虑整体以患者为中心的护理。

相似文献

3
Weightbearing and Activity Restriction Treatments and Quality of Life in Patients with Perthes Disease.
Clin Orthop Relat Res. 2021 Jun 1;479(6):1360-1370. doi: 10.1097/CORR.0000000000001608.
7
Use of PROMIS® to screen for depression in children with arthritis.
Pediatr Rheumatol Online J. 2020 Nov 23;18(1):92. doi: 10.1186/s12969-020-00482-1.
8
Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment.
JAMA Pediatr. 2020 Nov 1;174(11):e202861. doi: 10.1001/jamapediatrics.2020.2861. Epub 2020 Nov 2.
9
Health-related quality of life among pediatric patients with acute lymphoblastic leukemia: An exploratory cross-sectional study.
Pediatr Blood Cancer. 2024 Oct;71(10):e31186. doi: 10.1002/pbc.31186. Epub 2024 Jul 12.

本文引用的文献

1
Agreement Between Child Self-report and Caregiver-Proxy Report for Symptoms and Functioning of Children Undergoing Cancer Treatment.
JAMA Pediatr. 2020 Nov 1;174(11):e202861. doi: 10.1001/jamapediatrics.2020.2861. Epub 2020 Nov 2.
4
Patient reported outcomes can improve performance status assessment: a pilot study.
J Patient Rep Outcomes. 2019 Jul 16;3(1):41. doi: 10.1186/s41687-019-0136-z.
6
Global Oncology.
JAMA. 2019 Aug 6;322(5):397-398. doi: 10.1001/jama.2019.7081.
7
Survival of children with endemic Burkitt lymphoma in a prospective clinical care project in Uganda.
Pediatr Blood Cancer. 2019 Sep;66(9):e27813. doi: 10.1002/pbc.27813. Epub 2019 Jun 3.
8
Science and health for all children with cancer.
Science. 2019 Mar 15;363(6432):1182-1186. doi: 10.1126/science.aaw4892.
9
PROMIS pediatric measures validated in a longitudinal study design in pediatric oncology.
Pediatr Blood Cancer. 2019 May;66(5):e27606. doi: 10.1002/pbc.27606. Epub 2019 Jan 21.
10
The importance of patient-reported outcomes in clinical trials and strategies for future optimization.
Patient Relat Outcome Meas. 2018 Nov 1;9:353-367. doi: 10.2147/PROM.S156279. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验